AM-Pharma enrols first Covid-19 patients in Phase III clinical trial

Netherlands Enterprise Agency (RVO) extended an innovation credit of up to €5m to AM-Pharma for the Covid-19 trial. Credit: Gerd Altmann from Pixabay.